XML 145 R34.htm IDEA: XBRL DOCUMENT
v3.24.3

Share-based compensation and stockholders' equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Stockholders' Equity Note [Abstract] |
Schedule of Stock-based Compensation Expense | Share-based compensation expense, net of forfeitures was recorded in the following financial statement line items:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Cost of Commercial Product sales | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 0.1 |
Cost of MCM Product sales | 0.3 |  |  | 1.0 |  |  | 1.6 |  |  | 3.5 |
Cost of Bioservices | (0.1) |  |  | 0.2 |  |  | 0.2 |  |  | 0.8 |
R&D | — |  |  | 0.6 |  |  | 1.0 |  |  | 1.7 |
Selling, general and administrative | 2.1 |  |  | 2.2 |  |  | 10.9 |  |  | 13.0 |
Total share-based compensation expense | $ | 2.3 |  |  | $ | 4.0 |  |  | $ | 13.7 |  |  | $ | 19.1 |
Schedule of Stockholders' Equity Note, Warrants or Rights | As of September 30, 2024, the Company had the following Warrants outstanding to acquire shares of its common stock:
| Warrants Outstanding | Range of Exercise Price per Share | Expiration Date
Warrants issued related to the Term Loan Agreement | 2.5 | $9.88 - $15.72 | August 2029
Total | 2.5 |  |
Schedule of Accumulated Other Comprehensive Income (Loss) | The following table includes changes in accumulated other comprehensive income (loss), net of tax by component:
|  | Defined Benefit Pension Plan |  | Derivative Instruments |  | Foreign Currency Translation Adjustments |  | Total
Balance at December 31, 2023 |  | $ | — |  |  | $ | — |  |  | $ | (5.7) |  |  | $ | (5.7) |
Other comprehensive income before reclassifications |  | — |  |  | — |  |  | 0.2 |  |  | 0.2 |
Net current period other comprehensive income |  | — |  |  | — |  |  | 0.2 |  |  | 0.2 |
Balance at March 31, 2024 |  | $ | — |  |  | $ | — |  |  | $ | (5.5) |  |  | $ | (5.5) |
Other comprehensive income (loss) before reclassifications |  | — |  |  | — |  |  | — |  |  | — |
Net current period other comprehensive loss |  | — |  |  | — |  |  | — |  |  | — |
Balance at June 30, 2024 |  | $ | — |  |  | $ | — |  |  | $ | (5.5) |  |  | $ | (5.5) |
Other comprehensive income (loss) before reclassifications |  | — |  |  | — |  |  | (1.8) |  |  | (1.8) |
Net current period other comprehensive loss |  | — |  |  | — |  |  | (1.8) |  |  | (1.8) |
Balance at September 30, 2024 |  | $ | — |  |  | $ | — |  |  | $ | (7.3) |  |  | $ | (7.3) |
Balance at December 31, 2022 |  | $ | 3.5 |  |  | $ | 6.2 |  |  | $ | (6.6) |  |  | $ | 3.1 |
Other comprehensive loss before reclassifications |  | — |  |  | (4.4) |  |  | (0.1) |  |  | (4.5) |
Amounts reclassified from accumulated other comprehensive income |  | — |  |  | 2.4 |  |  | — |  |  | 2.4 |
Net current period other comprehensive loss |  | — |  |  | (2.0) |  |  | (0.1) |  |  | (2.1) |
Balance at March 31, 2023 |  | $ | 3.5 |  |  | $ | 4.2 |  |  | $ | (6.7) |  |  | $ | 1.0 |
Other comprehensive income before reclassifications |  | — |  |  | 1.2 |  |  | 2.6 |  |  | 3.8 |
Amounts reclassified from accumulated other comprehensive loss |  | (3.5) |  |  | (2.9) |  |  | — |  |  | (6.4) |
Net current period other comprehensive income (loss) |  | (3.5) |  |  | (1.7) |  |  | 2.6 |  |  | (2.6) |
Balance at June 30, 2023 |  | $ | — |  |  | $ | 2.5 |  |  | $ | (4.1) |  |  | $ | (1.6) |
Other comprehensive income (loss) before reclassifications |  | — |  |  | 0.9 |  |  | 1.2 |  |  | 2.1 |
Amounts reclassified from accumulated other comprehensive income (loss) |  | — |  |  | (3.1) |  |  | — |  |  | (3.1) |
Net current period other comprehensive income (loss) |  | — |  |  | (2.2) |  |  | 1.2 |  |  | (1.0) |
Balance at September 30, 2023 |  | $ | — |  |  | $ | 0.3 |  |  | $ | (2.9) |  |  | $ | (2.6) |
Schedule of Comprehensive Income (Loss) | The tables below present the tax effects related to each component of other comprehensive income (loss):
| Three Months Ended September 30,
| 2024 |  | 2023
| Pretax |  | Tax Expense |  | Net of tax |  | Pretax |  | Tax Expense |  | Net of tax
Derivative instruments | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (3.1) |  |  | $ | 0.9 |  |  | $ | (2.2) |
Foreign currency translation adjustments | (1.8) |  |  | — |  |  | (1.8) |  |  | 0.9 |  |  | 0.3 |  |  | 1.2 |
Total adjustments | $ | (1.8) |  |  | $ | — |  |  | $ | (1.8) |  |  | $ | (2.2) |  |  | $ | 1.2 |  |  | $ | (1.0) |
| Nine Months Ended September 30,
| 2024 |  | 2023
| Pretax |  | Tax Expense |  | Net of tax |  | Pretax |  | Tax Expense |  | Net of tax
Defined benefit pension plan | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (4.1) |  |  | $ | 0.6 |  |  | $ | (3.5) |
Derivative instruments | — |  |  | — |  |  | — |  |  | (8.0) |  |  | 2.1 |  |  | (5.9) |
Foreign currency translation adjustments | (1.6) |  |  | — |  |  | (1.6) |  |  | 2.9 |  |  | 0.8 |  |  | 3.7 |
Total adjustments | $ | (1.6) |  |  | $ | — |  |  | $ | (1.6) |  |  | $ | (9.2) |  |  | $ | 3.5 |  |  | $ | (5.7) |

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Paragraph 1 -Section 45 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1 + Details
Name: | us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration